Answers are grounded in this paper and cite their sources.
Per- and polyfluoroalkyl substances (PFAS), including perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS), are persistent environmental pollutants epidemiologically and experimentally linked to colorectal cancer (CRC) risk and progression. However, candidate molecular mediators potentially linking PFAS exposure with CRC biology remain incompletely characterized. We developed an integrative hypothesis-generating framework combining network toxicology, public transcriptomic analysis, and machine learning to prioritize candidate molecular nodes shared between the predicted PFAS chemical-protein interactome and the CRC-dysregulated transcriptome. A PFAS-CRC gene signature-based diagnostic model was constructed and externally validated. Public single-cell sequencing data analysis was used to reveal the expression and role of key genes in the tumor microenvironment. Molecular docking and dynamics simulations were used to evaluate predicted structural interactions between PFAS and candidate proteins. Finally, the potential mechanism of the key gene CDKN2A in CRC was validated through RT-qPCR and Western blot assays. Ninety-two candidate genes at the predicted PFAS–CRC molecular interface were identified, forming a densely connected protein-protein interaction network enriched in cancer-relevant pathways. Five core genes (CDKN2A, CCND1, BCL2, HSP90AB1, and MYC) were prioritized by convergent machine-learning algorithms. Among these candidates, high CDKN2A expression was associated with poor overall survival in the TCGA-CRC cohort. In vitro, PFOA or PFOS exposure increased CDKN2A expression and PI3K/AKT phosphorylation in SW480 and HCT116 CRC cells, whereas CDKN2A knockdown markedly attenuated the PFAS-associated signaling and cell-viability responses. This study identifies candidate molecular networks at the PFAS–CRC interface and provides experimental evidence that CDKN2A contributes to PFAS-associated PI3K/AKT activation in CRC cell models. These findings support CDKN2A as a candidate CRC-associated biomarker and a putative contributor to PFAS-associated cellular responses, although its clinical and therapeutic relevance requires further validation.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: